ArticleScientific reports2025
AMPK affects the development of early-stage NAFLD by activating autophagy and fatty acid oxidation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Endothelial cell LGR4 maintains liver sinusoidal endothelial cell Identity and protects against hepatic steatosis.Life sciences · 2026Article
- Molecular Hydrogen as a Regulator of Mitochondrial Quality Control and Metabolic Reprogramming.International journal of molecular sciences · 2026Review
- Restoring Mitochondrial Homeostasis: Therapeutic Strategies for Metabolic Dysfunction-Associated Fatty Liver Disease.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Non-alcoholic fatty liver disease (NAFLD) ranks among the most common liver disorders, but the mechanisms underlying its early development are still not well understood. This study aims to compare the effects of varying degrees of lipid accumulation on autophagy and energy metabolism signaling pathways to further elucidate the early pathogenesis of NAFLD. Low-level and classical lipid accumulation models were generated in AML12 and HepG2 cells in vitro using various concentrations of oleic acid and palmitic acid. For in vivo models, Tyloxapol and high-fat diet were utilized to construct both low-level and classical lipid accumulation models. We used Western blot analysis to assess the phosphorylation status of peroxisome proliferator-activated receptor α (PPARα) and AMP-activated protein kinase (AMPK), as well as the expression levels of autophagy-related proteins. We found that low-level lipid accumulation models significantly promoted the expression of the lipid oxidation protein PPARα, and enhanced autophagy activity and AMPK phosphorylation. However, these positive effects were inhibited in classical lipid accumulation models. Our research identified a compensatory mechanism in the early stages of NAFLD. Appropriate lipid accumulation can increase the levels of fatty acid oxidation proteins and autophagy, potentially mediated by the energy metabolism regulator AMPK. This discovery offers additional theoretical insights into the onset and progression of early-stage NAFLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.